Literature DB >> 20658371

High incidence of clinically relevant depressive symptoms in vulnerable persons of 75 years or older living in the community.

Els Dozeman1, Harm W J van Marwijk, Digna J F van Schaik, Max L Stek, Henriette E van der Horst, Aartjan T F Beekman, Hein P van Hout.   

Abstract

OBJECTIVES: Clinically relevant depressive symptoms are highly prevalent in people who are 75 years of age or older. However, very old people with a vulnerable health status are under-represented in studies focussing on incidence and risk factors, while the risk of developing depressive symptoms is expected to be very high in this group. The incidence rates of clinically relevant depressive symptoms and their predictors were investigated in a vulnerable elderly population.
METHODS: In a community-based cohort, 651 vulnerable elderly (75+) people were identified by means of the COOP-WONCA charts (Dartmouth Coop Functional Health Assessment Charts/World Organisation of Family Doctors). To study the incidence of clinically relevant symptoms of depression and their predictors, 266 people with no symptoms (Centre for Epidemiologic Studies Depression Scale, CES-D score <16 at baseline) were selected and measured again at six and 18 months. The incidence of clinically relevant symptoms of depression was defined as a CES-D score > or =16, in combination with at least a five-point change between measurements. Logistic regression analyses were applied to determine risk indicators.
RESULTS: After 18 months, the incidence rate of all clinically relevant symptoms of depression was 48% (95% confidence interval, CI 44.2-51.8). No specific risk factors were identified within this population.
CONCLUSION: Our estimates of the incidence of depressive symptoms were considerably higher than those previously found in elderly populations living in the community. A vulnerable health status is associated with a high risk of depressive symptoms.

Entities:  

Mesh:

Year:  2010        PMID: 20658371     DOI: 10.1080/13607861003781817

Source DB:  PubMed          Journal:  Aging Ment Health        ISSN: 1360-7863            Impact factor:   3.658


  6 in total

1.  Low 25-hydroxyvitamin D concentrations predict incident depression in well-functioning older adults: the health, aging, and body composition study.

Authors:  Julie A Williams; Kaycee M Sink; Janet A Tooze; Hal H Atkinson; Jane A Cauley; Kristine Yaffe; Frances A Tylavsky; Susan M Rubin; Eleanor M Simonsick; Stephen B Kritchevsky; Denise K Houston
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2014-10-18       Impact factor: 6.053

2.  Depression, antidepressants, and falls among community-dwelling elderly people: the MOBILIZE Boston study.

Authors:  Lien Quach; Frances M Yang; Sarah D Berry; Elizabeth Newton; Richard N Jones; Jeffrey A Burr; Lewis A Lipsitz
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2013-07-01       Impact factor: 6.053

3.  Depressive symptoms, life satisfaction and prevalence of sleep disturbances in the general population of Germany: results from the Heinz Nixdorf Recall study.

Authors:  Maria Elena Lacruz; Andrea Schmidt-Pokrzywniak; Nico Dragano; Susanne Moebus; Susanne Eva Deutrich; Stefan Möhlenkamp; Axel Schmermund; Hagen Kaelsch; Raimund Erbel; Andreas Stang
Journal:  BMJ Open       Date:  2016-01-04       Impact factor: 2.692

4.  Predictors of Major Depressive Disorder in Older People.

Authors:  Susana Sousa; Constança Paúl; Laetitia Teixeira
Journal:  Int J Environ Res Public Health       Date:  2021-11-12       Impact factor: 3.390

5.  Instrumental Activities of Daily Living by Subjective and Objective Measures: The Impact of Depression and Personality.

Authors:  Katya Numbers; Sujin Jang; Henry Brodaty; Perminder S Sachdev; Brian Draper; Simone Reppermund
Journal:  Front Aging Neurosci       Date:  2022-07-22       Impact factor: 5.702

6.  Plasma biomarkers of depressive symptoms in older adults.

Authors:  S E Arnold; S X Xie; Y-Y Leung; L-S Wang; M A Kling; X Han; E J Kim; D A Wolk; D A Bennett; A Chen-Plotkin; M Grossman; W Hu; V M-Y Lee; R Scott Mackin; J Q Trojanowski; R S Wilson; L M Shaw
Journal:  Transl Psychiatry       Date:  2012-01-03       Impact factor: 6.222

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.